Lewis-Hall Freda C — SEC insider filings
SEC reporting owner CIK 1437909. 25 insider filings on record with FilingPulse; latest filed 2026-10-26.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2021-05-21 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) | Director | 6 | — | — | 15 |
| 1Life Healthcare Inc (ONEM) | Director | 3 | — | — | 8 |
| CDT Equity Inc. (CDT) | Director | 6 | — | — | 8 |
| Pyxis Oncology, Inc. (PYXS) | Director | 6 | — | — | 6 |
| EXACT SCIENCES CORP (EXAS) | Director | 3 | — | — | 3 |
| Helus Pharma Inc. (HELP) | Director | 1 | — | — | — |
Insider filings — Lewis-Hall Freda C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-26 | 3 | Helus Pharma Inc. (HELP) | Holdings only — no transactions reported | EDGAR |
| 2026-03-25 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 45,867 (derivative) @ $0 | EDGAR |
| 2025-08-26 | 4 | CDT Equity Inc. (CDT) | Grant/award (A): 35,000 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Disposition to issuer (D): 24,727 · Disposition to issuer (D): 29,983 (derivative) · Disposition to issuer (D): 7,464 (derivative) · Disposition to issuer (D): 15,318 (derivative) · Disposition to issuer (D): 13,774 (derivative) · Disposition to issuer (D): 12,216 (derivative) | EDGAR |
| 2025-05-15 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 10,060 @ $0 | EDGAR |
| 2025-04-02 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 36,979 (derivative) @ $0.98 | EDGAR |
| 2025-04-01 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 47,612 @ $0.89 | EDGAR |
| 2024-12-20 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 420,000 (derivative) @ $0.07 | EDGAR |
| 2024-11-20 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 437,976 @ $0.09 | EDGAR |
| 2024-05-17 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 4,095 @ $0 · Grant/award (A): 12,216 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) jointly with Intelmed LLC | Grant/award (A): 400,664 (derivative) · Grant/award (A): 103,397 (derivative) | EDGAR |
| 2024-03-28 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 35,219 @ $0 | EDGAR |
| 2023-12-14 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 65,000 (derivative) @ $5.51 | EDGAR |
| 2023-06-12 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 3,599 @ $0 | EDGAR |
| 2023-05-25 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 4,648 @ $0 · Grant/award (A): 13,774 (derivative) @ $0 | EDGAR |
| 2023-03-28 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 139,355 @ $0 | EDGAR |
| 2023-02-24 | 4 | 1Life Healthcare Inc (ONEM) | Disposition to issuer (D): 4,534 @ $18 · Disposition to issuer (D): 10,381 (derivative) · Disposition to issuer (D): 5,294 (derivative) · Disposition to issuer (D): 20,728 (derivative) | EDGAR |
| 2022-06-13 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 5,606 @ $0 | EDGAR |
| 2022-06-06 | 4 | 1Life Healthcare Inc (ONEM) | Option exercise (M): 4,534 · Option exercise (M): 4,534 (derivative) @ $0 · Grant/award (A): 20,728 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 4,818 @ $0 · Grant/award (A): 15,318 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 66,831 @ $0 | EDGAR |
| 2021-10-12 | 4 | Pyxis Oncology, Inc. (PYXS) | Grant/award (A): 42,191 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | EXACT SCIENCES CORP (EXAS) | Grant/award (A): 2,011 @ $0 | EDGAR |
| 2021-06-07 | 4 | 1Life Healthcare Inc (ONEM) | Grant/award (A): 4,534 (derivative) @ $0 | EDGAR |
| 2021-05-21 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 1,106 @ $0 · Grant/award (A): 6,998 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1437909 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs